Close Menu

NEW YORK (360Dx) – A group of researchers led by Guy's and St. Thomas' NHS Foundation Trust and King's College London has developed a method to clarify the adverse pregnancy outcomes and measure the risk of stillbirth in patients with intrahepatic cholestasis of pregnancy (ICP) by using a metadata analysis of patient cohorts from multiple studies. The researchers believe that the analysis can help clinicians stratify patient risk groups depending on the total concentration levels of bile in their systems.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.